Literature DB >> 20833957

Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72.

Andreas N Kavazis1, Ashley J Smuder, Kisuk Min, Nihal Tümer, Scott K Powers.   

Abstract

Doxorubicin (Dox) is an antitumor agent used in cancer treatment, but its clinical use is limited due to cardiotoxicity. Although exercise training can defend against Dox-mediated cardiac damage, the means for this cardioprotection remain unknown. To investigate the mechanism(s) responsible for exercise training-induced cardioprotection against Dox-mediated cardiotoxicity, we tested a two-pronged hypothesis: 1) exercise training protects against Dox-induced cardiotoxicity by preventing Dox-mediated mitochondrial damage/dysfunction and increased oxidative stress and 2) exercise training-induced cardiac expression of the inducible isoform of the 70-kDa heat shock protein 72 (HSP72) is essential to achieve exercise training-induced cardioprotection against Dox toxicity. Animals were randomly assigned to sedentary or exercise groups and paired with either placebo or Dox treatment (i.e., 20 mg/kg body wt ip Dox hydrochloride 24 h before euthanasia). Dox administration resulted in cardiac mitochondrial dysfunction, activation of proteases, and apoptosis. Exercise training increased cardiac antioxidant enzymes and HSP72 protein abundance and protected cardiac myocytes against Dox-induced mitochondrial damage, protease activation, and apoptosis. To determine whether exercise-induced expression of HSP72 in the heart is required for this cardioprotection, we utilized an innovative experimental strategy that successfully prevented exercise-induced increases in myocardial HSP72 levels. However, prevention of exercise-induced increases in myocardial HSP72 did not eliminate the exercise-induced cardioprotective phenotype that is resistant to Dox-mediated injury. Our results indicate that exercise training protects against the detrimental side effects of Dox in cardiac myocytes, in part, by protecting mitochondria against Dox-mediated damage. However, this exercise-induced cardioprotection is independent of myocardial HSP72 levels. Finally, our data are consistent with the concept that increases in cardiac mitochondrial antioxidant enzymes may contribute to exercise-induced cardioprotection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833957      PMCID: PMC2993189          DOI: 10.1152/ajpheart.00585.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  46 in total

Review 1.  Apoptosis in heart and skeletal muscle.

Authors:  Andy J Primeau; Peter J Adhihetty; David A Hood
Journal:  Can J Appl Physiol       Date:  2002-08

2.  Short-term exercise improves myocardial tolerance to in vivo ischemia-reperfusion in the rat.

Authors:  H A Demirel; S K Powers; M A Zergeroglu; R A Shanely; K Hamilton; J Coombes; H Naito
Journal:  J Appl Physiol (1985)       Date:  2001-11

Review 3.  Exercise preconditioning of the myocardium.

Authors:  Andreas N Kavazis
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

4.  Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress.

Authors:  Maria Cristina C Gomes-Marcondes; Michael J Tisdale
Journal:  Cancer Lett       Date:  2002-06-06       Impact factor: 8.679

5.  Effects of body temperature during exercise training on myocardial adaptations.

Authors:  M B Harris; J W Starnes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-05       Impact factor: 4.733

6.  Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis.

Authors:  Pattie S Green; Christiaan Leeuwenburgh
Journal:  Biochim Biophys Acta       Date:  2002-10-09

7.  Short-term exercise training can improve myocardial tolerance to I/R without elevation in heat shock proteins.

Authors:  K L Hamilton; S K Powers; T Sugiura; S Kim; S Lennon; N Tumer; J L Mehta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-09       Impact factor: 4.733

Review 8.  Adriamycin-induced heart failure: mechanism and modulation.

Authors:  P K Singal; T Li; D Kumar; I Danelisen; N Iliskovic
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

9.  Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.

Authors:  April C Childs; Sharon L Phaneuf; Amie J Dirks; Tracey Phillips; Christiaan Leeuwenburgh
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

10.  Exercise, antioxidants, and HSP72: protection against myocardial ischemia/reperfusion.

Authors:  Karyn L Hamilton; Jessica L Staib; Tracey Phillips; Andrea Hess; Shannon L Lennon; Scott K Powers
Journal:  Free Radic Biol Med       Date:  2003-04-01       Impact factor: 7.376

View more
  36 in total

1.  Endurance exercise attenuates ventilator-induced diaphragm dysfunction.

Authors:  Ashley J Smuder; Kisuk Min; Matthew B Hudson; Andreas N Kavazis; Oh-Sung Kwon; W Bradley Nelson; Scott K Powers
Journal:  J Appl Physiol (1985)       Date:  2011-11-10

2.  Short-term exercise training attenuates acute doxorubicin cardiotoxicity.

Authors:  Chia-Ying Lien; Brock T Jensen; David S Hydock; Reid Hayward
Journal:  J Physiol Biochem       Date:  2015-09-24       Impact factor: 4.158

3.  The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle.

Authors:  Laura A A Gilliam; Kelsey H Fisher-Wellman; Chien-Te Lin; Jill M Maples; Brook L Cathey; P Darrell Neufer
Journal:  Free Radic Biol Med       Date:  2013-09-07       Impact factor: 7.376

4.  Exercise Training Prevents Doxorubicin-induced Mitochondrial Dysfunction of the Liver.

Authors:  J Matthew Hinkley; Aaron B Morton; Noriko Ichinoseki-Sekine; Andres Mor Huertas; Ashley J Smuder
Journal:  Med Sci Sports Exerc       Date:  2019-06       Impact factor: 5.411

Review 5.  Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms.

Authors:  Jessica M Scott; Aarif Khakoo; John R Mackey; Mark J Haykowsky; Pamela S Douglas; Lee W Jones
Journal:  Circulation       Date:  2011-08-02       Impact factor: 29.690

6.  Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy.

Authors:  Kisuk Min; Oh-Sung Kwon; Ashley J Smuder; Michael P Wiggs; Kurt J Sollanek; Demetra D Christou; Jeung-Ki Yoo; Moon-Hyon Hwang; Hazel H Szeto; Andreas N Kavazis; Scott K Powers
Journal:  J Physiol       Date:  2015-02-23       Impact factor: 5.182

7.  Exercise stimulates beneficial adaptations to diminish doxorubicin-induced cellular toxicity.

Authors:  Ashley J Smuder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-08-28       Impact factor: 3.619

8.  Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes.

Authors:  Laura A A Gilliam; Jennifer S Moylan; Elaine W Patterson; Jeffrey D Smith; Anne S Wilson; Zaheen Rabbani; Michael B Reid
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-21       Impact factor: 4.249

9.  Patient preference and timing for exercise in breast cancer care.

Authors:  Kathleen M Sturgeon; Carla Fisher; Gina McShea; Susan Kruse Sullivan; Dahlia Sataloff; Kathryn H Schmitz
Journal:  Support Care Cancer       Date:  2017-08-24       Impact factor: 3.603

Review 10.  The effects of exercise on cardiovascular outcomes before, during, and after treatment for breast cancer.

Authors:  Kathleen M Sturgeon; Bonnie Ky; Joseph R Libonati; Kathryn H Schmitz
Journal:  Breast Cancer Res Treat       Date:  2013-12-14       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.